EL

Ellen ABFNSE Ellen Stock Report

Last reporting period 30 Jun, 2023

Updated 18 Oct, 2024

Last price

Market cap $B

0.001

Micro

Exchange

FNSE - First North Sweden

ELN.ST Stock Analysis

EL

Uncovered

Ellen AB is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

20/100

Low score

Market cap $B

0.001

Dividend yield

Shares outstanding

4.431 B

Ellen AB engages in the manufacturing and distribution of probiotic products for women. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2006-12-08. The Company’s main product, Ellen tampon, contains patented natural lacto acid bacteria, Lacto Naturel (LN), and is used for maintaining the vaginal health. The Ellen tampon is made of natural fibers treated with the substance LN, which consists of human lactic acid bacteria, a natural part of healthy women's defense against infections. Ellen AB distributes its products in 37 countries, including Scandinavian countries, France, Germany, Czech Republic, Spain, Portugal, Poland and Belgium, among others. As of December 31, 2011, the Company had two subsidiaries, including the wholly owned Ellen Australia pty LTD and the 70%-owned Ellen Asia LTD. As of December 31, 2011, its largest shareholder was Banque Ohman S.A. (18.73%). On July 3, 2013, it launched an online store, www.ellen.se, where customers can search for products' information and shop online.

View Section: Eyestock Rating